Using a special collagen material to help heal skull bone injuries
Mineralized collagen composite to accelerate craniofacial bone regeneration
This study is testing a new material that helps heal bone defects in the face and skull, making it easier and safer for patients to recover from injuries or surgeries.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Illinois at Urbana-Champaign NIH-funded |
| Lab location | 1 site (Champaign, United States) |
| Project ID | NIH-11083137 on NIH RePORTER |
What this research studies
This research focuses on developing a new biomaterial designed to enhance the healing of craniofacial bone defects, which can occur due to congenital issues, trauma, or medical treatments. The approach involves creating a mineralized collagen scaffold that mimics the properties of natural bone, allowing for better integration and regeneration. By utilizing this innovative material, the research aims to improve the healing process and reduce complications associated with traditional bone grafts and implants. Patients may benefit from a more effective and less invasive treatment option for craniofacial reconstruction.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with craniofacial bone defects resulting from congenital conditions, trauma, or cancer treatment.
Not a fit: Patients with stable craniofacial structures or those who do not require surgical intervention for bone defects may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with a more effective solution for craniofacial bone regeneration, leading to improved healing outcomes and reduced surgical complications.
How similar studies have performed: Previous research has shown promise in using biomaterials for bone regeneration, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Champaign, United States
- University of Illinois at Urbana-Champaign — Champaign, United States (Active)
Researchers
- Principal investigator: Harley, Brendan a. — University of Illinois at Urbana-Champaign
- Study coordinator: Harley, Brendan a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.